European Commission President Ursula Von der Leyen expects significantly more vaccine doses to be available in the European Union from next month.
“According to the manufacturers’ plans, the quantities could double again from April, also because more vaccines will be approved soon,” she told the Stuttgarter Zeitung and Stuttgarter Nachrichten.
She expects “an average of about 100 million doses per month in the second quarter, a total of 300 million by the end of June.”
According to the newspapers, this would mean about 20 million doses per month for Germany, which means that the injection capacity in the country will have to be increased considerably.
Since the vaccination began in late December, approximately 7.3 million doses have been administered in Germany, according to figures released Friday by the Robert Koch Institute (RKI), the German counterpart of RIVM. Just under half of the nearly 5 million Germans vaccinated have also received the second vaccination.
So far, vaccines from three manufacturers, Pfizer / BioNTech, Moderna and AstraZeneca, have been approved in the EU. On Thursday, the European Medicines Agency (EMA) is also expected to recommend the vaccine’s approval from Janssen company in Leiden.
